Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
03 2019
Historique:
received: 10 12 2017
accepted: 24 04 2018
pubmed: 5 5 2018
medline: 28 11 2019
entrez: 5 5 2018
Statut: ppublish

Résumé

To determine whether sleep disturbance and symptoms of depression mediate the relationship between pain and cognitive dysfunction (CD) in a sample of 115 patients with systemic lupus erythematosus (SLE). A total of 115 patients with SLE completed questionnaires regarding pain, perceived stress, depression, sleep, and CD. Relationships among pain, sleep, depression, and CD were assessed using bootstrap mediation models, controlling for race/ethnicity, fibromyalgia diagnosis, current corticosteroid use, disease activity and damage, and perceived stress. Mediation analyses indicated that the effect of pain on CD was mediated by sleep disturbance (β = 0.30) and depression symptoms (β = 0.33). These effects were maintained even after controlling for the aforementioned covariates, of which only disease activity (β = 0.20) and stress (β = 0.22) remained significantly linked to CD (overall model R After controlling for disease activity and perceived stress, the relationship between pain and CD was explained by sleep disturbance and depression symptoms. Although these relationships need validation in longitudinal studies with additional measurement modalities, our findings may indicate promising, nonpharmacologic intervention avenues for SLE patients with pain and CD. Specifically, cognitive behavioral therapies for depression and sleep are known to reduce distress and enhance functioning across various psychosocial domains. Given the symptom burden of SLE, interventions that maximize potential benefits without the use of additional pharmacologic treatments may be of particular utility.

Identifiants

pubmed: 29726637
doi: 10.1002/acr.23593
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-412

Subventions

Organisme : The Cornell Brewer Foundation
Pays : International

Informations de copyright

© 2018, American College of Rheumatology.

Auteurs

Teresa A Lillis (TA)

Rush University Medical Center, Chicago, Illinois.

Vanessa Tirone (V)

Rush University Medical Center, Chicago, Illinois.

Nisarg Gandhi (N)

John H. Stroger Hospital, Chicago, Illinois.

Stacy Weinberg (S)

Rush University Medical Center, Chicago, Illinois.

Ailda Nika (A)

Rush University Medical Center, Chicago, Illinois.

Winston Sequeira (W)

Rush University Medical Center, Chicago, Illinois.

Stevan E Hobfoll (SE)

Rush University Medical Center, Chicago, Illinois.

Joel A Block (JA)

Rush University Medical Center, Chicago, Illinois.

Meenakshi Jolly (M)

Rush University Medical Center, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH